Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P02774 (
Gc-globulin
)
196
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Gc-globulin
has been found in bronchoalveolar lavage fluid in patients with chronic obstructive pulmonary disease (COPD) and adult respiratory distress syndrome (ARDS) and has been shown to enhance neutrophil chemotaxis to C5-derived peptides in vitro. We proposed that
Gc-globulin
may enhance the inflammatory response in lungs by influencing monocyte chemotaxis to C5-derived peptides as it does with neutrophils. Monocyte chemotaxis was measured in blind well chambers by a leading-front technique. Purified human
Gc-globulin
had no intrinsic chemotactic activity for monocytes at concentrations ranging from 1 fM to 1 microM. However,
Gc-globulin
, at concentrations as low as 10 pM, increased monocyte chemotaxis over 10-fold in a concentration-dependent fashion when added to non-chemotactic doses of C5a (0.1 nM) and C5a des Arg (0.5 nM). The chemotaxis-enhancing effect of
Gc-globulin
was specific for C5-derived peptides, as
Gc-globulin
did not enhance monocyte chemotaxis to other chemoattractants such as leukotriene B4 or formyl-
Met
-Leu-Phe. The enhancement of monocyte chemotaxis to C5-derived peptides by
Gc-globulin
was not a nonspecific effect of anionic proteins, as other serum proteins of similar size and charge did not enhance monocyte chemotaxis to C5a des Arg. These results indicate that
Gc-globulin
enhances the monocyte response to C5-derived peptides and, together with previous work, indicates that its presence in the airways of patients with COPD and ARDS may up-regulate the monocyte inflammatory response in the lungs.
...
PMID:Human monocyte chemotaxis to complement-derived chemotaxins is enhanced by Gc-globulin. 812 Apr 52